Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma

[1]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[2]  Steven J. M. Jones,et al.  Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma , 2022, Nature Communications.

[3]  Chunyan-Zou,et al.  Potential Value of Circular RNA circTBC1D4 in Gastrointestinal Stromal Tumors , 2022, Journal of immunology research.

[4]  Minmin Shi,et al.  LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma , 2022, Journal of Hematology & Oncology.

[5]  Lihong Peng,et al.  EnANNDeep: An Ensemble-based lncRNA–protein Interaction Prediction Framework with Adaptive k-Nearest Neighbor Classifier and Deep Models , 2022, Interdisciplinary Sciences: Computational Life Sciences.

[6]  Lihong Peng,et al.  EnANNDeep: An Ensemble-based lncRNA–protein Interaction Prediction Framework with Adaptive k-Nearest Neighbor Classifier and Deep Models , 2022, Interdisciplinary Sciences: Computational Life Sciences.

[7]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[8]  M. Taherian,et al.  Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review. , 2021, Chinese clinical oncology.

[9]  A. Krasinskas,et al.  Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma , 2021, The American journal of surgical pathology.

[10]  Hantao Yao,et al.  Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics , 2021, Science advances.

[11]  C. Peng,et al.  Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway , 2021, Journal of experimental & clinical cancer research : CR.

[12]  Lihong Peng,et al.  LPI-deepGBDT: a multiple-layer deep framework based on gradient boosting decision trees for lncRNA–protein interaction identification , 2021, BMC Bioinformatics.

[13]  Sheng-ping Li,et al.  Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer , 2021, Journal of inflammation research.

[14]  I. Amelio,et al.  Understanding p53 tumour suppressor network , 2021, Biology direct.

[15]  I. Amelio,et al.  NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network , 2021, Biology direct.

[16]  Chang Chen,et al.  Long non-coding RNA PCED1B-AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR-411-3p/HIF-1α axis , 2021, Oncology reports.

[17]  Liqian ZhouZhou,et al.  LPI-deepGBDT: a multiple-layer deep framework based on gradient boosting decision trees for lncRNA–protein interaction identification , 2021, BMC Bioinform..

[18]  R. Pandey,et al.  Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma , 2021, Scientific Reports.

[19]  Jun Chen,et al.  Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma , 2020, Molecular medicine reports.

[20]  Yizhuo Wang,et al.  Silencing LINC00482 inhibits tumor-associated inflammation and angiogenesis through down-regulation of MMP-15 via FOXA1 in bladder cancer , 2020, Aging.

[21]  Xingjing Luo,et al.  Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function , 2020, BMB reports.

[22]  D. Beer,et al.  Silencing of LOC389641 impairs cell proliferation and induces autophagy via EGFR/MET signaling in lung adenocarcinoma , 2020, Aging.

[23]  He Huang,et al.  Noncoding RNAs in drug-resistant pancreatic cancer: A review. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  Xing-ming Jiang,et al.  LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis. , 2020, Pathology, research and practice.

[25]  G. Wahl,et al.  Tuft Cell Formation Reflects Epithelial Plasticity in Pancreatic Injury: Implications for Modeling Human Pancreatitis , 2020, Frontiers in Physiology.

[26]  F. Wang,et al.  Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients , 2019, Experimental and therapeutic medicine.

[27]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[28]  Z. Wang,et al.  Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma , 2019, Gut.

[29]  Shanglong Liu,et al.  The regulatory roles of long noncoding RNAs in the biological behavior of pancreatic cancer , 2019, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[30]  Wenjun Yang,et al.  LncRNA H19/miR‐194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer , 2018, Journal of cellular biochemistry.

[31]  Lengchen Hou,et al.  Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR‐381/CXCR4 axis , 2018, Journal of cellular physiology.

[32]  Na-Na Guan,et al.  Computational models for lncRNA function prediction and functional similarity calculation , 2018, Briefings in functional genomics.

[33]  J. Lehtiö,et al.  Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics , 2017, Metabolomics.

[34]  Xing Chen,et al.  Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..

[35]  K. Alitalo,et al.  PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma , 2016, BMC Cancer.

[36]  Xiaoyi Huang,et al.  LncRNAs in pancreatic cancer , 2016, Oncotarget.

[37]  Yimin Liu,et al.  Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. , 2015, World journal of gastroenterology.

[38]  T. Tsujiuchi,et al.  LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs , 2015, Molecular and Cellular Biochemistry.

[39]  Gabriela Kalna,et al.  Melanoma Cells Break Down LPA to Establish Local Gradients That Drive Chemotactic Dispersal , 2014, PLoS biology.

[40]  Hugues Bersini,et al.  Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages , 2012, BMC Bioinformatics.

[41]  J. George,et al.  Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis , 2011, PloS one.

[42]  G. Czirják,et al.  Targeting of Calcineurin to an NFAT-like Docking Site Is Required for the Calcium-dependent Activation of the Background K+ Channel, TRESK* , 2006, Journal of Biological Chemistry.

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..